TI
BMRN icon

Tidal Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Tidal Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
47,829
-616
-1% -$33.7K ﹤0.01% 1199
2026
Q1 		$2.68M Buy
48,445
+33,658
+228% +$1.96M 0.01% 1041
2025
Q4 		$879K Sell
14,787
-26,453
-64% -$1.44M ﹤0.01% 1347
2025
Q3 		$2.23M Buy
41,240
+9,915
+32% +$567K ﹤0.01% 861
2025
Q2 		$1.72M Buy
31,325
+10,083
+47% +$594K 0.01% 794
2025
Q1 		$1.5M Buy
21,242
+8,203
+63% +$552K 0.01% 816
2024
Q4 		$857K Sell
13,039
-17,428
-57% -$1.17M 0.01% 1088
2024
Q3 		$2.14M Buy
30,467
+18,300
+150% +$1.53M 0.02% 613
2024
Q2 		$1M Sell
12,167
-5,280
-30% -$440K 0.01% 896
2024
Q1 		$1.52M Buy
17,447
+6,906
+66% +$618K 0.03% 668
2023
Q4 		$1.02M Buy
10,541
+55
+0.5% +$4.87K 0.02% 623
2023
Q3 		$928K Buy
10,486
+568
+6% +$50.5K 0.03% 572
2023
Q2 		$860K Buy
9,918
+3,760
+61% +$354K 0.03% 589
2023
Q1 		$599K Buy
6,158
+388
+7% +$40.2K 0.02% 685
2022
Q4 		$597K Buy
5,770
+719
+14% +$67.5K 0.02% 606
2022
Q3 		$428K Buy
5,051
+284
+6% +$25.3K 0.02% 621
2022
Q2 		$395K Sell
4,767
-25
-0.5% -$1.99K 0.01% 678
2022
Q1 		$369K Buy
4,792
+474
+11% +$39.7K 0.01% 766
2021
Q4 		$381K Buy
4,318
+204
+5% +$16.8K 0.01% 694
2021
Q3 		$318K Buy
4,114
+655
+19% +$51.7K 0.01% 666
2021
Q2 		$289K Sell
3,459
-25
-0.7% -$1.98K 0.01% 585
2021
Q1 		$263K Buy
3,484
+1,023
+42% +$83.6K 0.01% 465
2020
Q4 		$216K Buy
+2,461
New +$195K 0.01% 379
2020
Q3 		– Sell
-1,653
Closed -$204K – 247
2020
Q2 		$204K Buy
+1,653
New +$164K 0.03% 287

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Tidal Investments's BMRN Position: Q2 2026 in Review

Tidal Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 1.3% in Q2 2026, selling an estimated $33.7K and leaving 47,829 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Tidal Investments first reported a position in BMRN in Q2 2020 and has held it in 24 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Tidal Investments held 47,829 shares of BioMarin Pharmaceuticals worth $2.74M as of Q2 2026.
  • Tidal Investments sold 616 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $33.7K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1199 holding.
  • Tidal Investments first reported a position in BioMarin Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.